Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Lokon Pharma AB
AB
Active
Org 5568712292
Bredgränd 14, 753 20
Uppsala
Manufacture of basic pharmaceutical products
·
NACE 2110
Est. 2011 · 14 years old
12 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of basic pharmaceutical products
/
Lokon Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
EBITDA
SEK millions
0M
-31M
-61M
-92M
-122M
2021: -68M
-68M
2021
2022: -73M (-7% vs 2021)
-73M
-7%
2022
2023: -98M (-34% vs 2022)
-98M
-34%
2023
2024: -78M (+20% vs 2023)
-78M
+20%
2024
2025: -29M (+63% vs 2024)
-29M
+63%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
0
0
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
−28 543
−77 589
−98 425
−72 561
−67 933
Depreciation & amort.
−0
−17
−18
−18
−18
EBIT
−28 543
−77 606
−98 443
−72 579
−67 951
Net financials
−507
−245
−508
−1
—
Profit before tax
−28 797
−77 728
−98 696
−72 580
−67 951
Tax
−0
−0
−0
−0
−0
Net profit
−28 797
−77 728
−98 696
−72 580
−67 951
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
4 341
13 740
23 875
14 751
14 116
Equity
877
868
847
558
838
Long-term debt
0
0
0
0
0
Short-term debt
3 464
12 872
23 028
14 193
13 278
Total debt
3 464
12 872
23 028
14 193
13 278
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2021
2025
Equity ratio
20,2 %
This company
38,2 %
Market median
This company
Market median
47% below market
2021
2025
Return on equity
<−999 %
This company
18,4 %
Market median
This company
Market median
>999% below market
2021
2025
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2021
2025
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2021
2025
Debt / equity
3,95×
This company
0,62×
Market median
This company
Market median
537% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Lokon Pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
